Health

Consumer health: Living with atrial fibrillation

At least 2.7 million people in the U.S. are living with atrial fibrillation, according to the American Heart Association. And because the risk of developing it increases with age and people are living longer, medical researchers ...

Medications

Common blood thinner may double as cancer therapy

Warfarin, a widely used blood thinner, appears to have potent anti-cancer properties, according to a study by Columbia University researchers. The study, conducted in human cells and in mice, found that warfarin stops tumors ...

Inflammatory disorders

Potential new therapy for Crohn's, colitis identified

People with inflammatory bowel disease (IBD) live with frequent, miserable episodes of abdominal pain, diarrhea and in severe cases, rectal bleeding. Standard treatments are aimed at directly suppressing inflammation, but ...

Medical research

Discovery reveals potential way to prevent heart attacks, strokes

Scientists at the University of Virginia School of Medicine have identified a potential way to head off heart attacks and strokes by strengthening the fibrous caps overlying atherosclerotic plaques that naturally accumulate ...

Medications

Zinc could be key to new diabetes treatments

Researchers at the University of St Andrews say a greater understanding of how zinc is handled in our body could lead to improved treatments for people with diabetes.

Diseases, Conditions, Syndromes

EMA has 'not yet reached conclusion' on AstraZeneca

The EU's drug regulator said Tuesday it is still deciding whether the AstraZeneca coronavirus vaccine causes blood clots, after one top official said there was a clear link.

page 3 from 40